Notably, the mTOR inhibitor rapamycin has been found to increase autophagy levels, reduce amyloid-beta and phosphorylated tau levels, and improve cognition in AD mouse models (Yang and Zhang, 2020). This evidence concerns the gene MAPT and Alzheimer disease.